CYP7B1 and type 2 diabetes mellitus: Interestingly, the alternative bile acid synthesis pathway seems to be differentially altered in metabolic-related disorders, since CYP7B1 has been described as decreased in murine models as well as patients with type 2 diabetes [10,39,40] but was found elevated in patients with progressive MAFLD [41].